Example of Recent Patents on Anti-Infective Drug Discovery format
Recent searches

Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format Example of Recent Patents on Anti-Infective Drug Discovery format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access ISSN: 1574891X

Recent Patents on Anti-Infective Drug Discovery — Template for authors

Publisher: Bentham Science
Categories Rank Trend in last 3 yrs
Pharmacology (medical) #143 of 246 -
Infectious Diseases #178 of 288 down down by 8 ranks
Drug Discovery #103 of 145 down down by 3 ranks
journal-quality-icon Journal quality:
Medium
calendar-icon Last 4 years overview: 50 Published Papers | 118 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 18/06/2020
Insights & related journals
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Journal Performance & Insights

  • CiteRatio
  • SJR
  • SNIP

CiteRatio is a measure of average citations received per peer-reviewed paper published in the journal.

2.4

20% from 2019

CiteRatio for Recent Patents on Anti-Infective Drug Discovery from 2016 - 2020
Year Value
2020 2.4
2019 2.0
2018 2.4
2017 2.1
2016 3.5
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has increased by 20% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR) measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

0.341

23% from 2019

SJR for Recent Patents on Anti-Infective Drug Discovery from 2016 - 2020
Year Value
2020 0.341
2019 0.278
2018 0.378
2017 0.376
2016 0.521
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 23% in last years.
  • This journal’s SJR is in the top 10 percentile category.

Source Normalized Impact per Paper (SNIP) measures actual citations received relative to citations expected for the journal's category.

0.685

62% from 2019

SNIP for Recent Patents on Anti-Infective Drug Discovery from 2016 - 2020
Year Value
2020 0.685
2019 0.423
2018 0.535
2017 0.388
2016 0.883
graph view Graph view
table view Table view

insights Insights

  • SNIP of this journal has increased by 62% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Related Journals

open access Open Access ISSN: 16874757 e-ISSN: 16874765

Hindawi

CiteRatio: 6.3 | SJR: 1.164 | SNIP: 1.413
open access Open Access ISSN: 3057453 e-ISSN: 14602091
recommended Recommended

Oxford University Press

CiteRatio: 9.1 | SJR: 2.124 | SNIP: 1.646
open access Open Access ISSN: 664804 e-ISSN: 10986596
recommended Recommended

American Society for Microbiology

CiteRatio: 9.1 | SJR: 2.07 | SNIP: 1.44
open access Open Access ISSN: 9248579 e-ISSN: 18727913
recommended Recommended

Elsevier

CiteRatio: 12.0 | SJR: 1.454 | SNIP: 1.438
Recent Patents on Anti-Infective Drug Discovery

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Bentham Science

Recent Patents on Anti-Infective Drug Discovery

Approved by publishing and review experts on SciSpace, this template is built as per for Recent Patents on Anti-Infective Drug Discovery formatting guidelines as mentioned in Bentham Science author instructions. The current version was created on 18 Jun 2020 and has been used by 261 authors to write and format their manuscripts to this journal.

Medicine

i
Last updated on
18 Jun 2020
i
ISSN
1574-891X
i
Impact Factor
Medium - 0.593
i
Open Access
No
i
Sherpa RoMEO Archiving Policy
Yellow faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
Vancouver
i
Citation Type
Numbered
[25]
i
Bibliography Example
Blonder, G E, Tinkham, M, & Klapwijk, T M. Transition from metallic to tunnel- ing regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys. Rev. B. 2013;87(10):100510.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.2174/1574891X113089990012
Antimicrobial Photodynamic Therapy to Kill Gram-negative Bacteria
Felipe F. Sperandio1, Ying-Ying Huang, Michael R. Hamblin

Abstract:

Antimicrobial photodynamic therapy (PDT) or photodynamic inactivation (PDI) is a new promising strategy to eradicate pathogenic microorganisms such as Gram-positive and Gram-negative bacteria, yeasts and fungi. The search for new approaches that can kill bacteria but do not induce the appearance of undesired drug-resistant st... Antimicrobial photodynamic therapy (PDT) or photodynamic inactivation (PDI) is a new promising strategy to eradicate pathogenic microorganisms such as Gram-positive and Gram-negative bacteria, yeasts and fungi. The search for new approaches that can kill bacteria but do not induce the appearance of undesired drug-resistant strains suggests that PDT may have advantages over traditional antibiotic therapy. PDT is a non-thermal photochemical reaction that involves the simultaneous presence of visible light, oxygen and a dye or photosensitizer (PS). Several PS have been studied for their ability to bind to bacteria and efficiently generate reactive oxygen species (ROS) upon photo-stimulation. ROS are formed through type I or II mechanisms and may inactivate several classes of microbial cells including Gram-negative bacteria such as Pseudomonas aeruginosa, which are typically characterized by an impermeable outer cell membrane that contains endotoxins and blocks antibiotics, dyes, and detergents, protecting the sensitive inner membrane and cell wall. This review covers significant peer-reviewed articles together with US and World patents that were filed within the past few years and that relate to the eradication of Gram-negative bacteria via PDI or PDT. It is organized mainly according to the nature of the PS involved and includes natural or synthetic food dyes; cationic dyes such as methylene blue and toluidine blue; tetrapyrrole derivatives such as phthalocyanines, chlorins, porphyrins, chlorophyll and bacteriochlorophyll derivatives; functionalized fullerenes; nanoparticles combined with different PS; other formulations designed to target PS to bacteria; photoactive materials and surfaces; conjugates between PS and polycationic polymers or antibodies; and permeabilizing agents such as EDTA, PMNP and CaCl2. The present review also covers the different laboratory animal models normally used to treat Gram-negative bacterial infections with antimicrobial PDT. read more read less

Topics:

Gram-negative bacteria (54%)54% related to the paper, Photodynamic therapy (53%)53% related to the paper, Photosensitizer (51%)51% related to the paper, Antimicrobial (51%)51% related to the paper
314 Citations
open accessOpen access Journal Article DOI: 10.2174/157489110791233522
Topical Antimicrobials for Burn Wound Infections

Abstract:

Throughout most of history, serious burns occupying a large percentage of body surface area were an almost certain death sentence because of subsequent infection. A number of factors such as disruption of the skin barrier, ready availability of bacterial nutrients in the burn milieu, destruction of the vascular supply to the ... Throughout most of history, serious burns occupying a large percentage of body surface area were an almost certain death sentence because of subsequent infection. A number of factors such as disruption of the skin barrier, ready availability of bacterial nutrients in the burn milieu, destruction of the vascular supply to the burned skin, and systemic disturbances lead to immunosuppression combined together to make burns particularly susceptible to infection. In the 20th century the introduction of antibiotic and antifungal drugs, the use of topical antimicrobials that could be applied to burns, and widespread adoption of early excision and grafting all helped to dramatically increase survival. However the relentless increase in microbial resistance to antibiotics and other antimicrobials has led to a renewed search for alternative approaches to prevent and combat burn infections. This review will cover patented strategies that have been issued or filed with regard to new topical agents, preparations, and methods of combating burn infections. Animal models that are used in preclinical studies are discussed. Various silver preparations (nanocrystalline and slow release) are the mainstay of many approaches but antimicrobial peptides, topical photodynamic therapy, chitosan preparations, new iodine delivery formulations, phage therapy and natural products such as honey and essential oils have all been tested. This active area of research will continue to provide new topical antimicrobials for burns that will battle against growing multi-drug resistance. read more read less
190 Citations
Journal Article DOI: 10.2174/157489109787236256
Inhibitors of multidrug resistant efflux systems in bacteria.

Abstract:

Resistance of bacteria to many classes of antibiotics is an increasing problem worldwide. Multidrug resistance efflux pumps are recognized as an important component of resistance in both Gram-positive and Gram-negative bacteria. Some bacterial efflux pumps may be selective for one substrate, such as tetracycline, or transport... Resistance of bacteria to many classes of antibiotics is an increasing problem worldwide. Multidrug resistance efflux pumps are recognized as an important component of resistance in both Gram-positive and Gram-negative bacteria. Some bacterial efflux pumps may be selective for one substrate, such as tetracycline, or transport antibiotics of different classes, conferring a multiple drug resistance (MDR) phenotype. Efflux pump inhibitors (EPIs) are promising therapeutic agents, as they should restore the activity of standard antibiotics. The efflux pump inhibitor-antibiotic combination is expected to increase the intracellular concentration of antibiotics that are expelled by efflux pumps, decrease the intrinsic bacterial resistance to antibiotics, reverse the acquired resistance associated with efflux pumps overexpression, and reduce the frequency of the emergence of resistant mutant strains. In recent years, different classes of EPIs have been described and tested, including analogues of antibiotic substrates and new molecules. This review focuses on the families of MDR efflux pumps, and on the current progress for the clinical use of EPIs. The present article is a good review of the recent patents related to efflux pump inhibitors. read more read less

Topics:

Efflux (61%)61% related to the paper, Antibiotic resistance (57%)57% related to the paper, Multiple drug resistance (55%)55% related to the paper, Drug resistance (53%)53% related to the paper
143 Citations
Journal Article DOI: 10.2174/157489109789318569
Biological activities of pyrazoline derivatives--a recent development.
Suresh Kumar1, Sandhya Bawa, Sushma Drabu, Rajiv Kumar, Himanshu Gupta

Abstract:

Pyrazolines are well known and important nitrogen containing 5-membered heterocyclic compounds and various methods have been worked out for their synthesis. Numerous pyrazoline derivatives have been found to possess considerable biological activities, which stimulated the research activity in this field. They have several pro... Pyrazolines are well known and important nitrogen containing 5-membered heterocyclic compounds and various methods have been worked out for their synthesis. Numerous pyrazoline derivatives have been found to possess considerable biological activities, which stimulated the research activity in this field. They have several prominent effects, such as antimicrobial, antimycobacterial, antifungal, antiamoebic, anti-inflammatory, analgesic, antidepressant and anticancer activities. They also possess some potent receptor selective biological activity like Nitric oxide synthase (NOS) inhibitor and Cannabinoid CB1 receptor antagonists activity. 4,5-dihydro-1H- pyrazolines seem to be the most frequently studied pyrazoline type compounds. As a result, a large number of such pyrazolines using different synthetic methods for their preparation have been described in the chemistry literature. The present review provides an insight view to pyrazolines synthesis and its biological activities along with the compilation of recent patents on pyrazolines. read more read less

Topics:

Pyrazoline (61%)61% related to the paper
138 Citations
Journal Article DOI: 10.2174/1574891X11308010012
Bacterial quorum sensing inhibitors: attractive alternatives for control of infectious pathogens showing multiple drug resistance.

Abstract:

Quorum sensing (QS) is a bacterial communication process that depends on the bacterial population density. It involves small diffusible signaling molecules which activate the expression of myriad genes that control diverse array of functions like bioluminescence, virulence, biofilm formation, sporulation, to name a few. Since... Quorum sensing (QS) is a bacterial communication process that depends on the bacterial population density. It involves small diffusible signaling molecules which activate the expression of myriad genes that control diverse array of functions like bioluminescence, virulence, biofilm formation, sporulation, to name a few. Since QS is responsible for virulence in the clinically relevant bacteria, inhibition of QS appears to be a promising strategy to control these pathogenic bacteria. With indiscriminate use of antibiotics, there has been an alarming increase in the number of antibiotic resistant pathogens. Antibiotics are no longer the magic bullets they were once thought to be and therefore there is a need for development of new antibiotics and/or other novel strategies to combat the infections caused by multidrug resistant organisms. Quorum sensing inhibition or quorum quenching has been pursued as one of such novel strategies. While antibiotics kill or slow down the growth of bacteria, quorum sensing inhibitors (QSIs) or quorum quenchers (QQs) attenuate bacterial virulence. A large body of work on QS has been carried out in deadly pathogens like Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio fischeri, V. harveyi, Escherichia coli and V. cholerae etc to unravel the mechanisms of QS as well as identify and study QSIs. This review describes various aspects of QS, QSI, different model systems to study these phenomena and recent patents on various QSIs. It suggests QSIs as attractive alternatives for controlling human, animal and plant pathogens and their utility in agriculture and other industries. read more read less

Topics:

Quorum sensing (63%)63% related to the paper, Quorum Quenching (62%)62% related to the paper, Pseudomonas aeruginosa (50%)50% related to the paper
138 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Recent Patents on Anti-Infective Drug Discovery.

It automatically formats your research paper to Bentham Science formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Recent Patents on Anti-Infective Drug Discovery format uses Vancouver citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Recent Patents on Anti-Infective Drug Discovery in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Recent Patents on Anti-Infective Drug Discovery guidelines and auto format it.

2. Do you follow the Recent Patents on Anti-Infective Drug Discovery guidelines?

Yes, the template is compliant with the Recent Patents on Anti-Infective Drug Discovery guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Recent Patents on Anti-Infective Drug Discovery?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Recent Patents on Anti-Infective Drug Discovery citation style.

4. Can I use the Recent Patents on Anti-Infective Drug Discovery templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Recent Patents on Anti-Infective Drug Discovery.

5. Can I use a manuscript in Recent Patents on Anti-Infective Drug Discovery that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Recent Patents on Anti-Infective Drug Discovery that you can download at the end.

6. How long does it usually take you to format my papers in Recent Patents on Anti-Infective Drug Discovery?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Recent Patents on Anti-Infective Drug Discovery.

7. Where can I find the template for the Recent Patents on Anti-Infective Drug Discovery?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Recent Patents on Anti-Infective Drug Discovery's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Recent Patents on Anti-Infective Drug Discovery's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Recent Patents on Anti-Infective Drug Discovery an online tool or is there a desktop version?

SciSpace's Recent Patents on Anti-Infective Drug Discovery is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Recent Patents on Anti-Infective Drug Discovery?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Recent Patents on Anti-Infective Drug Discovery?”

11. What is the output that I would get after using Recent Patents on Anti-Infective Drug Discovery?

After writing your paper autoformatting in Recent Patents on Anti-Infective Drug Discovery, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Recent Patents on Anti-Infective Drug Discovery's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Recent Patents on Anti-Infective Drug Discovery?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Recent Patents on Anti-Infective Drug Discovery. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Recent Patents on Anti-Infective Drug Discovery?

The 5 most common citation types in order of usage for Recent Patents on Anti-Infective Drug Discovery are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Recent Patents on Anti-Infective Drug Discovery?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Recent Patents on Anti-Infective Drug Discovery's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Recent Patents on Anti-Infective Drug Discovery in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Recent Patents on Anti-Infective Drug Discovery Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Recent Patents on Anti-Infective Drug Discovery formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template